Logo image of TLPH

TALPHERA INC (TLPH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TLPH - US00444T2096 - Common Stock

1.14 USD
+0.06 (+5.56%)
Last: 12/31/2025, 8:00:01 PM
1.1 USD
-0.04 (-3.51%)
After Hours: 12/31/2025, 8:00:01 PM
Fundamental Rating

2

TLPH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. TLPH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TLPH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

TLPH had negative earnings in the past year.
TLPH had a negative operating cash flow in the past year.
TLPH had negative earnings in 4 of the past 5 years.
TLPH had a negative operating cash flow in each of the past 5 years.
TLPH Yearly Net Income VS EBIT VS OCF VS FCFTLPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

With a Return On Assets value of -40.30%, TLPH perfoms like the industry average, outperforming 43.46% of the companies in the same industry.
TLPH has a Return On Equity (-64.60%) which is in line with its industry peers.
Industry RankSector Rank
ROA -40.3%
ROE -64.6%
ROIC N/A
ROA(3y)-24.13%
ROA(5y)-35.67%
ROE(3y)-32.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TLPH Yearly ROA, ROE, ROICTLPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

TLPH's Gross Margin of 12540700.00% is amongst the best of the industry. TLPH outperforms 100.00% of its industry peers.
The Profit Margin and Operating Margin are not available for TLPH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12540700%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TLPH Yearly Profit, Operating, Gross MarginsTLPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200K 400K 600K

5

2. Health

2.1 Basic Checks

TLPH does not have a ROIC to compare to the WACC, probably because it is not profitable.
TLPH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TLPH has more shares outstanding
There is no outstanding debt for TLPH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TLPH Yearly Shares OutstandingTLPH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
TLPH Yearly Total Debt VS Total AssetsTLPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

TLPH has an Altman-Z score of -19.21. This is a bad value and indicates that TLPH is not financially healthy and even has some risk of bankruptcy.
TLPH has a worse Altman-Z score (-19.21) than 83.25% of its industry peers.
TLPH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -19.21
ROIC/WACCN/A
WACC9.26%
TLPH Yearly LT Debt VS Equity VS FCFTLPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

TLPH has a Current Ratio of 6.83. This indicates that TLPH is financially healthy and has no problem in meeting its short term obligations.
TLPH has a better Current ratio (6.83) than 69.63% of its industry peers.
A Quick Ratio of -1.30 indicates that TLPH may have some problems paying its short term obligations.
TLPH's Quick ratio of -1.30 is on the low side compared to the rest of the industry. TLPH is outperformed by 96.86% of its industry peers.
Industry RankSector Rank
Current Ratio 6.83
Quick Ratio -1.3
TLPH Yearly Current Assets VS Current LiabilitesTLPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

TLPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.93%, which is quite impressive.
Looking at the last year, TLPH shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)44.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 20.30% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y30%
EPS Next 2Y14.02%
EPS Next 3Y6.27%
EPS Next 5Y20.3%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TLPH Yearly Revenue VS EstimatesTLPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M 100M
TLPH Yearly EPS VS EstimatesTLPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 5 -5 -10 -15 -20

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TLPH. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TLPH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLPH Price Earnings VS Forward Price EarningsTLPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TLPH is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.53
TLPH Per share dataTLPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.02%
EPS Next 3Y6.27%

0

5. Dividend

5.1 Amount

TLPH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

TALPHERA INC

NASDAQ:TLPH (12/31/2025, 8:00:01 PM)

After market: 1.1 -0.04 (-3.51%)

1.14

+0.06 (+5.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-30 2026-03-30/amc
Inst Owners31.69%
Inst Owner ChangeN/A
Ins Owners8.9%
Ins Owner Change0.33%
Market Cap53.14M
Revenue(TTM)28.00K
Net Income(TTM)-12.39M
Analysts82.22
Price Target4.25 (272.81%)
Short Float %6.72%
Short Ratio5.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend23.88
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.47%
Min EPS beat(2)1.96%
Max EPS beat(2)22.97%
EPS beat(4)4
Avg EPS beat(4)29.17%
Min EPS beat(4)1.96%
Max EPS beat(4)57.11%
EPS beat(8)7
Avg EPS beat(8)24.45%
EPS beat(12)10
Avg EPS beat(12)20.71%
EPS beat(16)14
Avg EPS beat(16)19.45%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)46.67%
EPS NY rev (1m)30%
EPS NY rev (3m)30%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.85%
Revenue NY rev (3m)1.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1897.69
P/FCF N/A
P/OCF N/A
P/B 2.77
P/tB N/A
EV/EBITDA 0.53
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-31.11
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0
BVpS0.41
TBVpS-5.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -40.3%
ROE -64.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12540700%
FCFM N/A
ROA(3y)-24.13%
ROA(5y)-35.67%
ROE(3y)-32.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 130.74%
Cap/Sales 5136790%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.83
Quick Ratio -1.3
Altman-Z -19.21
F-Score5
WACC9.26%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y30%
EPS Next 2Y14.02%
EPS Next 3Y6.27%
EPS Next 5Y20.3%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7496.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.06%
OCF growth 3YN/A
OCF growth 5YN/A

TALPHERA INC / TLPH FAQ

What is the fundamental rating for TLPH stock?

ChartMill assigns a fundamental rating of 2 / 10 to TLPH.


What is the valuation status of TALPHERA INC (TLPH) stock?

ChartMill assigns a valuation rating of 1 / 10 to TALPHERA INC (TLPH). This can be considered as Overvalued.


How profitable is TALPHERA INC (TLPH) stock?

TALPHERA INC (TLPH) has a profitability rating of 1 / 10.


What is the financial health of TALPHERA INC (TLPH) stock?

The financial health rating of TALPHERA INC (TLPH) is 5 / 10.